Childhood acute lymphoblastic leukemia in Norway 1992 - 2000;Akutt lymfatisk leukemi hos barn i Norge 1992-2000

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 11, 2007, Pages 1493-1495

  Kolmannskog, Svein ^a,g   Flægstad, Trond ^b,c   Helgestad, Jon ^d,h   Hellebostad, Marit ^e   Zeller, Bernward ^f   Glomstein, Anders ^f  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b Barneavdelingen   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250019575     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 5. utg. Philadelphia: Lippincott Williams & Wilkins, 2006.
2. Helgestad J, Madsen B. Kreftoverlevelse hos barn. Tidsskr Nor Lægeforen 2005; 125: 2491-2.
3. Farber S, Diamond LK, Mercer RD et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-amino-pteroylglutamic acid (aminopterin). N Engl J Med 1948; 238: 787-93.
4. Pinkel D. Five-year follow up of «total therapy» of childhood lymphocytic leukaemia. JAMA 1971; 216: 648-52.
5. Moe PJ, Seip M, Finne PH. Intermediate dose methotrexate in childhood acute lymphocytic leukaemia. Acta Paediatr Scand 1981; 70: 73-9.
6. Moe PJ, Seip M, Finne PH et al. Barn med akutt lymfatisk leukemi. Langtidsprognose, en oppfølging av et landsmateriale behandlet med metotrexatstøt. Tidsskr Nor Lægeforen 1986; 106: 2621-3.
7. Gustafsson G, Kreuger A, Clausen N et al. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2684 patients diagnosed between 1981 and 1996. Acta Paediatr 1998; 87: 1151-61.
8. Gustafsson G, Schmiegelow K, Forestier E et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 2000; 14: 2267-75.
9. Saarinen-Pihkala UM, Gustafsson G, Carlsen N et al. Outcome of children with high-risk acute lymphoblastic leukaemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation. Pediatr Blood Cancer 2004; 42: 8-23.
10. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972; 34: 187-220.
11. Christensen MS, Heyman M, Möttönen M et al. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001. Br J Haematol 2005; 131: 50-8.